Fri Sep 20 06:03:08 UTC 2024: ## Microbot Medical Outshines Treace Medical Concepts in Stock Analysis: MarketBeat Report

**September 20, 2024** – MarketBeat News has compared two small-cap medical companies, Treace Medical Concepts (TMCI) and Microbot Medical (MBOT), based on various factors including earnings, valuation, analyst recommendations, and institutional ownership.

While Treace Medical Concepts has a lower price-to-earnings ratio, indicating affordability, **Microbot Medical emerged as the stronger contender in 7 out of 13 factors analyzed.**

**Key Findings:**

* **Earnings:** Microbot Medical boasts higher earnings despite lower revenue than Treace Medical Concepts.
* **Analyst Recommendations:** Microbot Medical has a stronger consensus rating and a significantly higher potential upside, indicating analysts favor it over Treace Medical Concepts.
* **Volatility:** Treace Medical Concepts displays lower volatility, while Microbot Medical exhibits higher volatility compared to the S&P 500.
* **Institutional Ownership:** Microbot Medical has a higher percentage of institutional investors, suggesting confidence in its long-term growth potential.

**Company Background:**

Treace Medical Concepts specializes in bunion correction systems, offering surgical instruments, implants, and techniques. Microbot Medical focuses on robotic endoluminal surgery devices for minimally invasive procedures, offering systems for various vascular interventions.

**Conclusion:**

Based on MarketBeat’s analysis, **Microbot Medical appears to be the more favorable investment option** due to its stronger earnings, positive analyst sentiment, and significant upside potential. However, investors should consider their own risk tolerance and investment goals before making any decisions.

Read More